Nano-Cap New Millennium Growth Fund’s Bicycle Therapeutics BCYC Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Buy	+80,000	New	+$367K	0.26%	92

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc London $602M AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's BCYC Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund opened a new position in Bicycle Therapeutics (BCYC) in Q2 2026: 80,000 shares worth $339K. The stake represents 0.26% of the portfolio and ranks #92 among its holdings.

104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

Nano-Cap New Millennium Growth Fund held 80,000 shares of Bicycle Therapeutics worth $339K as of Q2 2026.
Bicycle Therapeutics was a new Nano-Cap New Millennium Growth Fund position in Q2 2026.
Bicycle Therapeutics made up 0.26% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #92 holding.
104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.